Published in Mol Cell Biol on June 01, 1999
Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol (2004) 1.89
Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet (2013) 1.87
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. FASEB J (2011) 1.17
A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16
ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression. Mol Cell Biol (2004) 1.07
The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism. Mol Cell Biol (2004) 1.02
Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic Hrk gene in hematopoietic progenitor cells. EMBO J (2001) 0.95
Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol Cell Biol (2004) 0.94
Identification and analysis of genes and pseudogenes within duplicated regions in the human and mouse genomes. PLoS Comput Biol (2006) 0.90
Transcriptional repressor erf determines extraembryonic ectoderm differentiation. Mol Cell Biol (2007) 0.88
Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells. Cell Commun Signal (2015) 0.87
Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells. Mol Biol Cell (2012) 0.86
Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle. Mol Biol Cell (2007) 0.85
ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype. Cell Adh Migr (2012) 0.81
Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism. Mol Cancer (2011) 0.80
Expression of Hr-Erf Gene during Ascidian Embryogenesis. Balsaenggwa Saengsig (2013) 0.75
Go in! Go out! Inducible control of nuclear localization. Curr Opin Chem Biol (2016) 0.75
Quantitative Phospho-proteomic Analysis of TNFα/NFκB Signaling Reveals a Role for RIPK1 Phosphorylation in Suppressing Necrotic Cell Death. Mol Cell Proteomics (2017) 0.75
The Ets2 repressor factor (Erf) is required for effective primitive and definitive hematopoiesis. Mol Cell Biol (2017) 0.75
Rho GTPases and the actin cytoskeleton. Science (1998) 28.19
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 21.15
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell (1994) 16.30
The stress-activated protein kinase subfamily of c-Jun kinases. Nature (1994) 11.45
A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A (1995) 10.25
The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell (1995) 9.82
Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell (1995) 9.30
Mitogen-activated protein kinase pathways. Curr Opin Cell Biol (1997) 9.10
Nucleocytoplasmic transport. Science (1996) 8.76
Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (1995) 7.37
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell (1997) 6.55
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem (1995) 6.25
Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol (1996) 5.99
Integration of MAP kinase signal transduction pathways at the serum response element. Science (1995) 5.45
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem (1996) 5.42
Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature (1997) 4.59
The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell (1994) 4.30
ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J (1995) 4.28
Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science (1996) 4.03
ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J (1995) 3.93
Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell (1998) 3.80
Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol (1995) 3.79
Ras effectors. Curr Opin Cell Biol (1996) 3.28
Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature (1984) 3.15
Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J Biol Chem (1996) 3.11
Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J (1997) 2.99
Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol (1996) 2.79
Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway. Cell (1995) 2.61
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature (1997) 2.60
Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol (1997) 2.58
Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell (1998) 2.57
Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J (1998) 2.54
Nucleocytoplasmic transport of macromolecules. Microbiol Mol Biol Rev (1997) 2.51
The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol Cell Biol (1998) 2.44
The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway. Nature (1994) 2.44
Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science (1997) 2.25
The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO J (1996) 2.13
MAP kinase signaling specificity mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C. elegans vulval induction. Cell (1998) 1.84
Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J (1996) 1.77
Regulation of transcription factor localization: fine-tuning of gene expression. Trends Biochem Sci (1996) 1.76
Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol Cell Biol (1997) 1.69
The regulation of protein transport to the nucleus by phosphorylation. Biochem J (1995) 1.52
The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene (1996) 1.48
Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr Biol (1997) 1.41
Analysis of the ERK-stimulated ETS transcription factor ER81. Mol Cell Biol (1996) 1.36
Ets transcription factors and human disease. Biochim Biophys Acta (1998) 1.30
MAP kinase binds to the NH2-terminal activation domain of c-Myc. FEBS Lett (1994) 1.21
Reversion of Ras transformed cells by Ets transdominant mutants. Oncogene (1994) 1.14
Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Oncogene (1993) 1.12
Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv Cancer Res (1998) 1.11
The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA. Oncogene (1996) 1.10
Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J Biol Chem (1998) 1.02
ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. Oncogene (1996) 1.00
Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene (1996) 0.96
Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene (1996) 0.94
Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF. Biochem Biophys Res Commun (1997) 0.90
ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes. Oncogene (1997) 0.82
PE-1, a novel ETS oncogene family member, localizes to chromosome 1q21-q23. Genomics (1994) 0.80
High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif. Oncogene (1991) 1.45
Multiple regulatory regions on the 5' side of the mouse E alpha gene. Proc Natl Acad Sci U S A (1988) 1.38
Defining target sequences of DNA-binding proteins by random selection and PCR: determination of the GCN4 binding sequence repertoire. DNA Cell Biol (1990) 1.35
FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia (2000) 1.16
Human ERG-2 protein is a phosphorylated DNA-binding protein--a distinct member of the ets family. Oncogene (1993) 1.04
Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding. J Biol Chem (1992) 1.00
ETS family of genes in leukemia and Down syndrome. Am J Med Genet Suppl (1990) 0.89
ets-1 in astrocytes: expression and transmitter-evoked phosphorylation. Mol Cell Biol (1995) 0.87
ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes. Oncogene (1997) 0.82
ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL. Leukemia (1997) 0.82
Integrating an evidence-based intervention into clinical practice: 'transitional relationship model'. J Psychiatr Ment Health Nurs (2012) 0.80
Poly(amidoamine)s with potential as drug carriers: degradation and cellular toxicity. J Biomater Sci Polym Ed (1991) 0.79
A polymer-Triton X-100 conjugate capable of PH-dependent red blood cell lysis: a model system illustrating the possibility of drug delivery within acidic intracellular compartments. J Drug Target (1994) 0.78
Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids. Cancer Gene Ther (2000) 0.78
Pulmonary infection in mild variant cystic fibrosis: implications for care. J Cyst Fibros (2006) 0.77
Molecular and phylogenetic analysis of Greek measles 2010 strains. Epidemiol Infect (2011) 0.77
Topical nitroglycerin as an aid to insertion of peripheral venous catheters in neonates. J Pediatr (1989) 0.76
The ETS family of genes: structural analysis, gene products, and involvement in neoplasia and other pathologies. Prog Clin Biol Res (1990) 0.76
[Puncture of peripheral veins in newborn infants and infants]. Arch Fr Pediatr (1987) 0.75
[Trismus and tetanus vaccine]. Arch Pediatr (1999) 0.75
[Relapsing suppurative acute thyroiditis in children. 2 case reports (author's transl)]. Arch Fr Pediatr (1981) 0.75
[Acute nalidixic acid poisoning in children]. Arch Fr Pediatr (1978) 0.75
A question of status. Can Nurse (1988) 0.75
[Cowpox virus infection in a child]. Arch Pediatr (2004) 0.75
[Not Available]. Revue Stomatol (1955) 0.75
[Benigne multi-recurrent meningitis (Mollaret's disease). A case in a child of 2 years and 8 months]. Rev Neurol (Paris) (1977) 0.75
[Transcutaneous passage of trinitrine in the infant]. Therapie (1988) 0.75